New drug tested for stubborn Hormone-Linked high blood pressure
NCT ID NCT04605549
Summary
This study tested an investigational drug called CIN-107 for adults with primary aldosteronism, a condition where the adrenal glands produce too much of a hormone, causing hard-to-control high blood pressure. The main goals were to see if the drug was safe and if it could effectively lower blood pressure over 12 weeks, with an option for some patients to continue for over a year to check long-term safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY ALDOSTERONISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Greenbrae, California, 94904, United States
-
Research Site
San Francisco, California, 94110, United States
-
Research Site
West Hollywood, California, 90048, United States
-
Research Site
Chicago, Illinois, 60611, United States
-
Research Site
Baltimore, Maryland, 21287, United States
-
Research Site
Ann Arbor, Michigan, 48109, United States
-
Research Site
Rochester, Minnesota, 55905, United States
-
Research Site
Cincinnati, Ohio, 45245, United States
-
Research Site
Columbus, Ohio, 43210, United States
-
Research Site
Dallas, Texas, 75390-9047, United States
Conditions
Explore the condition pages connected to this study.